万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>细胞生物学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>免疫学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>病理学

HLA《人类白细胞抗原》 (官网投稿)

简介
  • 期刊简称HLA
  • 参考译名《人类白细胞抗原》
  • 核心类别 SCIE(2024版), 目次收录(维普),外文期刊,
  • IF影响因子
  • 自引率28.60%
  • 主要研究方向医学-PATHOLOGY 病理学;CELL BIOLOGY 细胞生物学;IMMUNOLOGY 免疫学

主要研究方向:

等待设置主要研究方向
医学-PATHOLOGY 病理学;CELL BIOLOGY 细胞生物学;IMMUNOLOGY 免疫学

HLA《人类白细胞抗原》(月刊). HLA publishes full-length original articles, brief communications, commentaries and occasional reviews on research in: immunoge...[显示全部]
征稿信息

万维提示:

1、投稿方式在线投稿。

2期刊网址:

https://onlinelibrary.wiley.com/journal/20592310

3投稿网址:https://wiley.atyponrex.com/journal/TAN

4、官网邮箱:HLA@wiley.com(编辑部)

steven.marsh@ucl.ac.uk(主编)

5、期刊刊期:月刊,一年出版12期。

2021年8月27日星期

                                 

 

投稿须知【官网信息】

 

Author Guidelines

1. Submission and Peer Review Process

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://wiley.atyponrex.com/journal/TAN

For help with submissions, please contact: HLA@wiley.com

This journal does not charge submission fees.

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

New submissions should be made via the Research Exchange submission portal. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com.

Open Access

You’ll have the option to choose to make your article open access after acceptance, which will be subject to an APC. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver.

Preprint policy:

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

HLA will consider for review articles previously available as preprints. You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.

Data Sharing and Data Availability

HLA recognizes the many benefits of archiving research data. HLA expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles https://www.force11.org/group/fairgroup/fairprinciples.

All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation policy.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more.

Scientific names and nomenclature

Official or standardized nomenclature should be used whenever available (e.g. the CD nomenclature for leukocyte differentiation antigens; official WHO Nomenclature for HLA).

Genetic Nomenclature

Original nucleotide or amino acid sequence data described in manuscripts must also be submitted to GenBank or ENA before submission. Manuscripts containing DNA or protein sequences without an accession number are not accepted.

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/20592310/homepage/forauthors.html


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭